Gene: HGD
Official Full Name: homogentisate 1,2-dioxygenaseprovided by HGNC
Gene Summary: This gene encodes the enzyme homogentisate 1,2 dioxygenase. This enzyme is involved in the catabolism of the amino acids tyrosine and phenylalanine. Mutations in this gene are the cause of the autosomal recessive metabolism disorder alkaptonuria.[provided by RefSeq, May 2010]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO37396 | HGD Knockout cell line (A549) | Human | HGD | 1:3~1:4 | Negative | Online Inquiry |
HGD Gene Knockout Cell Lines are specially engineered cellular models that have undergone targeted gene disruption to silence the activity of the hydroxyphenylglycine decarboxylase (HGD) gene. This gene is crucial for the catalysis of hydroxyphenylpyruvate into homogentisate, an important step in the catabolism of phenylalanine and tyrosine. By utilizing CRISPR-Cas9 or other gene editing technologies, these knockout cell lines exhibit a complete ablation of HGD function, thus allowing researchers to investigate the metabolic pathways affected by its loss.
The primary function of HGD Gene Knockout Cell Lines lies in their ability to facilitate studies on metabolic disorders, particularly Alkaptonuria, a rare genetic condition resulting from HGD deficiencies. With these cell lines, scientists can delve into the pathogenic mechanisms underlying the accumulation of homogentisate and related metabolites, significantly advancing our understanding of associated chronic conditions and potential therapeutic interventions.
In research settings, these knockout cell lines serve as indispensable tools for drug discovery and testing, offering insights into the efficacy and safety profiles of compounds aimed at modulating the metabolic pathway. Furthermore, because they mimic specific pathological conditions, they contribute valuable data for preclinical studies and biopharmaceutical development.
Compared to conventional wild-type cell lines, HGD Gene Knockout Cell Lines provide a more precise and reliable experimental system. They stabilize the genetic backdrop, ensuring reproducibility and streamlining the identification of HGD-related biochemical alterations without the confounding effects seen in heterozygous models.
For researchers and clinicians focused on metabolic diseases and therapeutic innovation, HGD Gene Knockout Cell Lines represent a unique asset. They not only facilitate a deeper comprehension of enzyme dysfunction but also foster the exploration of novel therapeutic strategies. At [Company Name], we are dedicated to producing high-quality biological products, backed by cutting-edge research and a commitment to advancing scientific discovery in the field of genetics and metabolism.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.